GEETA, GEETA
 Distribuzione geografica
Continente #
NA - Nord America 1.732
EU - Europa 973
AS - Asia 486
SA - Sud America 18
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 3.223
Nazione #
US - Stati Uniti d'America 1.707
IT - Italia 270
DE - Germania 228
SG - Singapore 196
CN - Cina 135
IE - Irlanda 104
SE - Svezia 94
RU - Federazione Russa 72
HK - Hong Kong 49
GB - Regno Unito 41
PL - Polonia 37
FR - Francia 32
ID - Indonesia 28
IN - India 27
UA - Ucraina 26
CA - Canada 23
BE - Belgio 14
BR - Brasile 14
DK - Danimarca 11
NL - Olanda 11
TR - Turchia 11
VN - Vietnam 9
FI - Finlandia 8
IR - Iran 8
JP - Giappone 8
AT - Austria 6
GR - Grecia 5
EU - Europa 4
KR - Corea 3
NO - Norvegia 3
PE - Perù 3
BD - Bangladesh 2
CH - Svizzera 2
DZ - Algeria 2
ES - Italia 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
SO - Somalia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
EG - Egitto 1
IS - Islanda 1
KE - Kenya 1
MK - Macedonia 1
MX - Messico 1
NG - Nigeria 1
PR - Porto Rico 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
TW - Taiwan 1
Totale 3.223
Città #
Ann Arbor 673
Frankfurt am Main 187
Chandler 124
Wilmington 118
Milan 108
Fairfield 107
Dublin 103
Singapore 103
Ashburn 68
Woodbridge 56
Hong Kong 45
New York 45
Dearborn 42
Seattle 40
Houston 36
Lodz 36
Cambridge 33
Princeton 30
Jakarta 28
Santa Clara 23
Shanghai 21
Nanjing 16
Los Angeles 15
Brussels 14
Lawrence 14
Fremont 13
Beijing 11
Altamura 10
Ottawa 10
Council Bluffs 9
Hangzhou 9
Jacksonville 9
Moscow 9
Andover 7
Norwalk 7
Nuremberg 7
San Diego 7
Chicago 6
Edmonton 6
Guangzhou 6
Helsinki 6
Jinan 6
Monza 6
Changsha 5
Columbus 5
Corsico 5
Hebei 5
Kiev 5
Nanchang 5
Redmond 5
Romola 5
Shenyang 5
Toronto 5
Aylesbury 4
Bergamo 4
Cagliari 4
Como 4
Dong Ket 4
Erzurum 4
Lissone 4
London 4
Meaux 4
Mumbai 4
Zhengzhou 4
Athens 3
Boardman 3
Bonndorf 3
Central District 3
Duncan 3
Düsseldorf 3
Falls Church 3
Hayward 3
Istanbul 3
Kocaeli 3
Kunming 3
Ningbo 3
Osaka 3
Osio Sotto 3
Oslo 3
Pune 3
Taizhou 3
Tianjin 3
Torino 3
Trento 3
Vercelli 3
Vienna 3
Washington 3
Amman 2
Amsterdam 2
Bari 2
Beledweyne 2
Bishkek 2
Bothell 2
Bradford 2
Casale Monferrato 2
Cernusco sul Naviglio 2
Changchun 2
Chennai 2
Cinisello Balsamo 2
Ciserano 2
Totale 2.418
Nome #
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 368
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 333
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates 302
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 271
In vitro and in vivo characterization of resistance to lorlatinib treatment in ALK mutated cancers 257
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 223
Abstract 902: In vitro andin vivocharacterization of resistance to lorlatinib treatment in ALK mutated cancers 206
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 203
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes 186
We shall overcome (drug resistance) some day 180
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma 172
Phase ii study with crizotinib in patients with anaplastic lymphoma kinase (alk)-positive lymphoma relapsed/refractory to chemotherapy 158
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 143
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma 137
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 119
New advances in liquid biopsy technologies for anaplastic lymphoma kinase (Alk)—positive cancer 103
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 64
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 13
Totale 3.438
Categoria #
all - tutte 11.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 0 0 0 0 0 0 0 0 64 42 23
2020/2021751 23 29 66 66 64 99 72 92 59 58 59 64
2021/2022314 42 56 40 25 16 16 20 9 13 15 26 36
2022/2023567 53 150 72 51 45 76 7 35 22 39 9 8
2023/2024361 7 10 20 17 32 93 58 24 37 14 10 39
2024/2025677 50 74 33 50 116 52 82 33 126 61 0 0
Totale 3.438